John Crowley

John Crowley is the current Chairman & CEO of Amicus Therapeutics. John has previously served as an Officer in the US Navy Reserve, CEO of Orexigen Therapeutics, SVP of Genzyme Therapeutics, and President & CEO of Novazyme Pharmaceuticals. John has also held positions as a Director at Bristol-Myers Squibb and an Associate at Marakon Associates and Bingham Summer Welsh & Spilman.

John Crowley has achieved a lot in their educational career. John has a Master of Business Administration from Harvard Business School, a Doctor of Law from Notre Dame Law School, and a BSFS in International Economics from Georgetown University. John also attended the United States Naval Academy.

Some individuals on their team include David Clark - Chief People Officer, Jayne C. Gershkowitz - Chief Patient Advocate, and Daphne Quimi - Chief Financial Officer.